CASP2 - RNA DOUBLE-STRANDED RNA COMPOUNDS TO CASP2 AND USES THEREOF
본 상세한 설명은 안질환, 장애 또는 손상으로 고통받거나 또는 이들로 발전할 위험이 있는 환자들을 치료하는 방법에 관한 것이고, 그리고 CASP2 발현을 하향-조절하는 이중-가닥 RNA 화합물 또는 그의 약제학적으로 수용가능한 염을 사용하는 치료요법을 포함한다. The present disclosure relates to methods of treating a patient suffering from or at risk of developing an ocular disease, disorder or injury, and includ...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English Korean |
Published |
11.12.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | 본 상세한 설명은 안질환, 장애 또는 손상으로 고통받거나 또는 이들로 발전할 위험이 있는 환자들을 치료하는 방법에 관한 것이고, 그리고 CASP2 발현을 하향-조절하는 이중-가닥 RNA 화합물 또는 그의 약제학적으로 수용가능한 염을 사용하는 치료요법을 포함한다.
The present disclosure relates to methods of treating a patient suffering from or at risk of developing an ocular disease, disorder or injury, and includes treatment regimens using a double-stranded RNA compound that down-regulates CASP2 expression, or a pharmaceutically acceptable salt thereof. |
---|---|
AbstractList | 본 상세한 설명은 안질환, 장애 또는 손상으로 고통받거나 또는 이들로 발전할 위험이 있는 환자들을 치료하는 방법에 관한 것이고, 그리고 CASP2 발현을 하향-조절하는 이중-가닥 RNA 화합물 또는 그의 약제학적으로 수용가능한 염을 사용하는 치료요법을 포함한다.
The present disclosure relates to methods of treating a patient suffering from or at risk of developing an ocular disease, disorder or injury, and includes treatment regimens using a double-stranded RNA compound that down-regulates CASP2 expression, or a pharmaceutically acceptable salt thereof. |
Author | ERLICH SHAI THOMPSON JAMES D OZDEN RABIA |
Author_xml | – fullname: ERLICH SHAI – fullname: OZDEN RABIA – fullname: THOMPSON JAMES D |
BookMark | eNrjYmDJy89L5WRwdnYMDjBS0FUI8nNUcPEPdfJx1Q0OCXL0c3F1AYs5-_sG-If6uQQrhPgrQBQDJRVCg12BIh6uQa7-bjwMrGmJOcWpvFCam0HZzTXE2UM3tSA_PrW4IDE5NS-1JN47yMjA0NLA0Njc0sTA0Zg4VQCV7i1l |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | CASP2에 대한 이중-가닥 RNA 화합물 및 그 용도 |
ExternalDocumentID | KR20190137940A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_KR20190137940A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:54:46 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English Korean |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_KR20190137940A3 |
Notes | Application Number: KR20197035560 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20191211&DB=EPODOC&CC=KR&NR=20190137940A |
ParticipantIDs | epo_espacenet_KR20190137940A |
PublicationCentury | 2000 |
PublicationDate | 20191211 |
PublicationDateYYYYMMDD | 2019-12-11 |
PublicationDate_xml | – month: 12 year: 2019 text: 20191211 day: 11 |
PublicationDecade | 2010 |
PublicationYear | 2019 |
RelatedCompanies | QUARK PHARMACEUTICALS, INC |
RelatedCompanies_xml | – name: QUARK PHARMACEUTICALS, INC |
Score | 3.1990361 |
Snippet | 본 상세한 설명은 안질환, 장애 또는 손상으로 고통받거나 또는 이들로 발전할 위험이 있는 환자들을 치료하는 방법에 관한 것이고, 그리고 CASP2 발현을 하향-조절하는 이중-가닥 RNA 화합물 또는 그의 약제학적으로 수용가능한 염을 사용하는 치료요법을 포함한다.
The present... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE |
Title | CASP2 - RNA DOUBLE-STRANDED RNA COMPOUNDS TO CASP2 AND USES THEREOF |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20191211&DB=EPODOC&locale=&CC=KR&NR=20190137940A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFPVNpzJ1SkDpW3FdP7I-DNmSluFcU7pW9jZMP0CUbbiK_77XuOme9pbkwnEJ_HL5JbkLwH2OewRDGl3dLCgSFGo6ujSpq2cZdfNuITPLqaKRx4EzTKynqT2twccmFkblCf1WyRERUSnivVTr9fL_EIurt5WrB_mGTYtHP-5xbc2OkXwgodH4oOeFggumMdYbRVoQKVmVXc-12v092MeNNFW07WVQxaUst52KfwIHIeqbl6dQe1804Iht_l5rwOF4feWNxTX6VmfAWH8SdohOoqBPuEgGz55e_XkccI-rNibGoUgCPiGxIL-dUUgSXDNJPPQiT_jncOd7MRvqaM3sb_CzUbRtunkB9flinjeBmI6RSyu309c0tTodKtvdAhGFPr2gbTvLLqG1S9PVbvE1HFfV6uGGYbSgXn5-5Tfofkt5q2btBzzRgSY |
link.rule.ids | 230,309,783,888,25577,76883 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFOebTsWPqQGlb8V17druYciWtFS3NqVrxbdh-gGibMNV_Pe9xk33tLdwF8Il8Mvll9xdAO5yPCNoQrNVvbCQoFi6qQrd6qlZZvVyuxCZYVbZyH5geonx9NJ9qcHHOhdG1gn9lsUREVEp4r2U-_Xi_xKLydjK5b14Q9H8wY37TFmxYyQfSGgUNuw7IWecKpT2R5ESRFJXVdfrGe3BDuziIduWZOl5WOWlLDadinsIeyGONyuPoPY-b0KDrv9ea8K-v3ryxuYKfctjoHQwCTtEJVEwIIwnw7GjVn8eB8xhUka5H_IkYBMSc_LbGZUkwT2TxJ4TOdw9gVvXiamnojXTv8lPR9Gm6fop1GfzWX4GRDe1XBh5N31NU6PTsUTbLhBR6NMLq93NsnNobRvpYrv6Bhpe7I-n48dgdAkHlaoK4tC0FtTLz6_8Cl1xKa7lCv4Ac4GEFg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=CASP2+-+RNA+DOUBLE-STRANDED+RNA+COMPOUNDS+TO+CASP2+AND+USES+THEREOF&rft.inventor=ERLICH+SHAI&rft.inventor=OZDEN+RABIA&rft.inventor=THOMPSON+JAMES+D&rft.date=2019-12-11&rft.externalDBID=A&rft.externalDocID=KR20190137940A |